Protective CD8+ T cell responses can be induced by activated dendritic cells in the inflammation of normal tissue [33], whereas an immune reaction to lung cancer in the presence of mature dendritic cells (activated or not) is necessary to organize cytotoxic T cells, which are associated with a good clinical outcome and response to therapeutics [34]. The gene discussed is CD8A; the disease is lung carcinoma.